Urinary Biomarkers of Bladder Cancer: An Update and Future Perspectives
- 17 September 2013
- journal article
- review article
- Published by Taylor & Francis in Biomarkers in Medicine
- Vol. 7 (5) , 779-790
Abstract
Bladder cancer is one of the most prevalent cancers worldwide. Early detection of bladder tumors is critical for improved patient outcomes. The standard method for detection and surveillance of bladder tumors is cystoscopy with urinary cytology. Limitations of cystoscopy and urinary cytology have brought to light the need for more robust diagnostic assays. Ideally, such assays would be applicable to noninvasively obtained, voided urine, and be designed not only for diagnosis, but also for monitoring disease recurrence and response to therapy. Consequently, the development of a noninvasive urine-based assay would be of tremendous benefit to both patients and healthcare systems. This article reports some of the more prominent urine-based biomarkers reported in the literature. In addition, some new technologies that have been used to identify novel urinary biomarkers are highlighted.Keywords
Funding Information
- Florida Department of Health James and Esther King Team Science (10KT-01)
This publication has 131 references indexed in Scilit:
- Influencing factors on the NMP-22 urine assay: an experimental modelBMC Urology, 2012
- IL-8 as a urinary biomarker for the detection of bladder cancerBMC Urology, 2012
- Vascular Endothelial Growth Factor, Carbonic Anhydrase 9, and Angiogenin as Urinary Biomarkers for Bladder Cancer DetectionUrology, 2012
- Detection of Bladder Cancer Using Novel DNA Methylation Biomarkers in Urine SedimentsCancer Epidemiology, Biomarkers & Prevention, 2011
- Urinary Glycoprotein Biomarker Discovery for Bladder Cancer Detection Using LC/MS-MS and Label-Free QuantificationClinical Cancer Research, 2011
- Association of hyaluronic acid family members (HAS1, HAS2, and HYAL‐1) with bladder cancer diagnosis and prognosisCancer, 2010
- Fluorescence in situ hybridization for detecting urothelial carcinomaCancer Cytopathology, 2010
- Bladder Cancer–Associated Gene Expression Signatures Identified by Profiling of Exfoliated UrotheliaCancer Epidemiology, Biomarkers & Prevention, 2009
- Quantitation of Aurora Kinase A Gene Copy Number in Urine Sediments and Bladder Cancer DetectionJNCI: Journal of the National Cancer Institute, 2008
- Improved breast cancer prognosis through the combination of clinical and genetic markersBioinformatics, 2006